Search alternatives:
significant effects » significant effect (Expand Search), significantly affected (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
effects decrease » effects decreased (Expand Search), effects regress (Expand Search)
significant effects » significant effect (Expand Search), significantly affected (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
effects decrease » effects decreased (Expand Search), effects regress (Expand Search)
-
1
Inotodiol decreases clone formation in HCC cells.
Published 2025“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”
-
2
-
3
-
4
-
5
Summary of significance levels for comparison of surgical segment ROM between different test groups.
Published 2025Subjects: -
6
-
7
-
8
-
9
Summary of clinical efficacy of relevant PTSD treatments.
Published 2025Subjects: “…demonstrate sustained effects…”
-
10
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count.
Published 2025“…(B) Long-term-treatment with a low dose of netoglitazone also exhibits a patchy effect in decreasing plaque count. This effect is mainly observed in the olfactory, hindbrain, and visual areas. …”
-
11
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: “…demonstrate sustained effects…”
-
12
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: “…demonstrate sustained effects…”
-
13
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: “…demonstrate sustained effects…”
-
14
Mean scores, standard deviations, and significance on key measures and subscales by gender group.
Published 2025Subjects: -
15
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: “…demonstrate sustained effects…”
-
16
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: “…demonstrate sustained effects…”
-
17
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: “…demonstrate sustained effects…”
-
18
-
19
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
Published 2025“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
-
20